Clinical Trials in San Francisco

Showing 4561-4580 of 12,991 trials

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

NCT05255445

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused recipients (RBC-IMPACT) is an observational cohort study to assess donor, component, and recipient factors that contribute to RBC efficacy in chronically and episodically transfused patients. The objective of the study is to determine how specific genetic and non-genetic factors in donors and recipients may impact RBC survival after transfusion - in short, what factors on both the donor and recipient side may improve the efficacy of the transfusion.

Sickle Cell DiseaseThalassemiaPediatric Cancer

Westat157 participantsStarted Mar 2022

Oakland, California, United States • San Francisco, California, United States • Boston, Massachusetts, United States +11 more locations

TERMINATEDPhase 2/3< 1 mile

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

NCT05305040

This is a Phase 3 study to evaluate posoleucel (ALVR105, Viralym-M); an allogeneic, off-the-shelf multi-virus specific T cell therapy that targets six viral pathogens: BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6 and JC virus.

Adenovirus InfectionBK Virus InfectionCytomegalovirus Infections+3 more

AlloVir451 participantsStarted Mar 2022

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Duarte, California, United States +85 more locations

Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Find Trials by Condition in San Francisco

Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

PrEP Intervention for People Who Inject Substances and Use Methamphetamine

Dopaminergic Mechanisms Underlying Human Social Behavior

Personalized Mobile Intervention to Reduce Exposure to Endocrine Disrupting Chemicals in Adults of Child-Bearing Age

A Study of Tirzepatide (LY3298176) In Participants After A Lifestyle Weight Loss Program

A Bot-based Self-help Program (WELL)

Botulinum Toxin Type A (AGN-151607) for the Prevention of Post-operative Atrial Fibrillation in Adult Participants Undergoing Open-chest Cardiac Surgery (NOVA)

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE)

Gan & Lee Insulin Glargine Target Type (1) Evaluating Research

A 2-Year Phase 3 Study Of CP-690,550 In Patients With Active Rheumatoid Arthritis On Background Methotrexate

Camsirubicin + Pegfilgrastim to Determine MTD in ASTS

89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

A Study of TAK-071 in People With Parkinson Disease

A Phase 1 Study to Investigate Axatilimab Alone or in Combination With Durvalumab in Patients With Solid Tumors

A Pilot Trial of Lithium in Subjects With Progressive Supranuclear Palsy or Corticobasal Degeneration

Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for Acute Treatment of Temporomandibular Disorders

Screening for Asymptomatic Coronary Artery Disease in Kidney Transplant Candidates